[Infusion therapy of acute vertebragenic pain syndrome].
In the course of a double blind study 67 patients with acute vertebragenic pain syndromes have been treated with 3 infusion solutions, which only differed from each other by the analgetic component. Nefopam as an analgeticum showed a clearly prolonged effect and a quicker analgetic effect. As far as pains which occurred during a resting period and pains which occurred during a movement were concerned no differences in the effect were observed. Patients treated with Nefo-Dolpasse showed a smaller rate of side effects than those treated with comparable solutions.
D000632:Aminopyrine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000700:Analgesics / Q000008:administration & dosage* / Q000009:adverse effects; D001416:Back Pain / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004177:Dipyrone / Q000008:administration & dosage; D004311:Double-Blind Method; D006801:Humans; D007262:Infusions, Intravenous; D009340:Nefopam / Q000008:administration & dosage; D011843:Radiculopathy / Q000188:drug therapy*
D000700:Analgesics; D000632:Aminopyrine; C017444:isopyrin; D009340:Nefopam; D004177:Dipyrone
Infusionstherapie akuter vertebragener Schmerz-syndrome.